HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
Yiwei HuangZhencong ChenTao LuGuoshu BiMing LiJiaqi LiangZhengyang HuYuansheng ZhengJiacheng YinJunjie XiZongwu LinCheng ZhanWei JiangQun WangLijie TanPublished in: Journal of experimental & clinical cancer research : CR (2021)
Our results indicated that HIF-1α functions as a critical factor in the dual role of TGF-β in tumor cells, and may be used as a biomarker or therapeutic target for TGF-β mediated cancer progression.